The c-Abl protein is a ubiquitously expressed nonreceptor tyrosine kinase involved in the development and function of many mammalian organ systems, including the immune system and bone. Here we show that homozygous Abl mutant embryos and newborns on the C57BL/6J background, but not on other backgrounds, display dramatically enlarged hearts and die perinatally. The heart defects can be largely rescued by cardiomyocyte-specific restoration of the full-length c-Abl protein. The cardiac hyperplasia phenotype is not caused by decreased apoptosis, but rather by abnormally increased cardiomyocyte proliferation during later stages of embryogenesis. Genes involved in cardiac stress and remodeling and cell cycle regulation are also up-regulated in the mutant hearts. These findings reveal an essential role for c-Abl in mammalian heart growth and development.
The c-Abl protein is a ubiquitously expressed nonreceptor tyrosine kinase involved in the development and function of many mammalian organ systems, including the immune system and bone. Here we show that homozygous Abl mutant embryos and newborns on the C57BL/6J background, but not on other backgrounds, display dramatically enlarged hearts and die perinatally. The heart defects can be largely rescued by cardiomyocyte-specific restoration of the full-length c-Abl protein. The cardiac hyperplasia phenotype is not caused by decreased apoptosis, but rather by abnormally increased cardiomyocyte proliferation during later stages of embryogenesis. Genes involved in cardiac stress and remodeling and cell cycle regulation are also up-regulated in the mutant hearts. These findings reveal an essential role for c-Abl in mammalian heart growth and development.
Abelson | heart development | hyperproliferation O rgan formation during embryogenesis is an intricate process in which multipotent progenitor cells commit to specific lineages and multiple differentiated cell types interact and organize into a precise 3-dimensional structure. To generate and maintain the proper size and shape of the mature organ, cell proliferation and differentiation need to be tightly regulated. The molecular mechanisms responsible for this delicate balance are complicated and remain poorly understood in many settings.
Cardiac ventricular chamber formation involves regulated cardiomyocyte proliferation and dynamic changes in myocardial architecture, including trabeculation and thickening of the initial compact layer (1) (2) (3) . The inner trabeculae in mouse hearts, which contain highly organized muscular ridges lined by endocardial cells, form as a result of interactions between primitive myocardium and endocardium over the time period from embryonic day (E) 9.5 to E13.5. The outer compact myocardium, distributed along the ventricular wall, is more mitotic and less differentiated than trabecular myocardium at this time. As morphogenesis of the ventricle progresses, the overall proliferative activity of cardiac progenitor cells gradually declines and is completely terminated soon after birth (4, 5) . How cardiac proliferation is regulated during later stages of embryogenesis is largely unknown. In particular, what triggers cardiomyocytes to withdraw from the cell cycle at birth is still unclear. c-Abl is a ubiquitously expressed nonreceptor tyrosine kinase implicated in the regulation of cell proliferation, survival, and migration (6) . c-Abl and its close relative Arg (i.e., Abl-related gene) share similar SH3, SH2, and tyrosine kinase domains with other Src-family members but, in addition, contain a unique large carboxyl-terminal fragment with multiple functional domains including proline-rich sequences, nuclear localization signals (NLSs), actin-binding domains and a nuclear export signal. Disruption of Abl in mice on a mixed genetic background results in neonatal lethality accompanied by pleiotropic developmental defects with variable penetrance, including runting, splenic and thymic atrophy, B cell lymphopenia, dysfunctional osteoblasts, and foreshortened crania (7) (8) (9) . Recent evidence also suggests a possible connection between c-Abl and heart development and physiology. It has been shown that the transmembrane sem-aphorin Sema6D signaling, likely mediated by c-Abl, promotes the migration of myocardium into the trabeculae in chicken embryos (10) . In humans and mice, the cancer therapeutic agent imatinib (Gleevec; Novartis), a small-molecule tyrosine kinase inhibitor, was reported to cause left ventricular contractile dysfunction and dilation (11) . Analysis of isolated cardiomyocytes from mice that had received imatinib revealed mitochondrial abnormalities, activation of the endoplasmic reticulum stress response, and consequent cell death. It is believed that imatinib-induced cardiotoxicity is mediated by inhibition of endogenous c-Abl. However, there remains no direct evidence of a role for c-Abl in mammalian cardiac growth and development. In this study, we report a previously unappreciated critical function for c-Abl in regulating cardiomyocyte proliferation during late mouse gestation. This finding not only reveals an unanticipated aspect of c-Abl biology, but also has implications for the possible side effects of imatinib on fetal cardiac development (12) .
Results
Severe Perinatal Lethality of Abl Mutant Mice on C57BL/6J Background.
To introduce an Abl knockout (KO) mutation into defined genetic backgrounds, we backcrossed Abl 2 (an Abl-null allele) heterozygous animals with 129/SvEv (129) and C57BL/6J (B6) inbred mice for more than 10 generations. Homozygous Abl KO animals were then generated by intercrossing heterozygous mice of the specific backgrounds. At postnatal day (P) 14, approximately 50% of the expected homozygous Abl mutant 129 or 129xB6 mice were viable, consistent with previous observations (8, 9) (Table 1) . However, on the B6 background, only 4% (1 of 28) of the expected homozygous Abl mutant mice survived at P14. Approximately 90% of these mice died between P0 and P1. In contrast, only 10% of the homozygous Abl KO 129xB6 mice were dead at birth ( Table 1 ). Analysis of offspring from timed matings of heterozygous mutant B6 mice revealed Abl −/− embryos between E14.5 and E18.5 surviving at a frequency slightly less than the expected Mendelian ratio, with occasional dead and degenerating mutant embryos ( Table 1 ). These data suggest that loss of c-Abl in mice on the B6 background causes a more severe phenotype than on a mixed background, with a high mortality rate between E18.5 and P1.
To rule out the possibility that the high perinatal lethality on the B6 background was caused by other spontaneous mutations arising in the course of the backcrossing, we also examined the effect of genetic background on another Abl mutant allele: Abl m1 . Unlike the null allele Abl 2 , Abl m1 eliminates only the carboxyl-terminal third of the c-Abl protein and replaces it with neomycin sequences (8) . However, it is known that the phenotypes of Abl 2 and Abl m1
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Freely available online through the PNAS open access option. 1 To whom correspondence may be addressed. E-mail: spg1@columbia.edu or ycang@ burnham.org. This article contains supporting information online at www.pnas.org/cgi/content/full/ 0913131107/DCSupplemental. mutant mice on a mixed background are indistinguishable (8, 9) . Abl m1 B6 mice were generated through independent multigenerational backcrossing to inbred B6 animals. Similar to Abl 2 null animals, Abl m1 homozygous mice also exhibited approximately 90% perinatal mortality on the B6 background (Table S1 ). This suggests that the perinatal lethality phenotype observed in Abl mutant animals is indeed a result of loss of c-Abl function.
Cardiac Abnormalities in Abl −/− Mice. To probe the cause(s) of perinatal lethality in the Abl 2 KO B6 mice, we performed a comprehensive histological analysis of WT and Abl −/− embryos and newborns. These surveys revealed no gross defects in the brain, lung, or liver. However, the hearts of mutant mice displayed dramatic morphological abnormalities of both ventricles and atria ( Fig. 1 A and C). As shown in Fig. 1A , most Abl KO embryos at E18.5 displayed enlarged ventricles and dilated atria when compared with WT controls. The heart weight-to-body weight ratio in the mutant embryos was approximately 30% higher than in WT littermates (5.87 mg/g ± 0.24 vs. 4.64 mg/g ± 0.19; P < 0.003; Fig. 1B ). More strikingly, histological serial sectioning of the mutant hearts revealed an almost complete disappearance of the 2 ventricular lumens in all Abl KO newborns that died at P0 (Fig. 1C ). Furthermore, the interventricular septum was also thickened in the mutant hearts. Histological analysis of embryos at E18.5 showed expansion of both the trabecular and compact layers of the 2 ventricles (Fig. 1C ). The early development of Abl mutant hearts appeared to be normal as revealed by sectioning of embryos at E14.5 (Fig. 1C ). Together, these observations indicate that the phenotype of the abnormally enlarged hearts in c-Abl-deficient mice develops during late gestation and peaks at birth. This correlates well with the timing of death of these mutant animals and suggests that severe cardiac defects might be the primary cause of death. In contrast, the hearts of Abl null mice on the 129xB6 mixed background, including those that died perinatally and neonatally, were grossly normal compared versus those of WT controls upon histological examination (Fig. 1C ). This indicates that the involvement of c-Abl in cardiac development is susceptible to modification by the mouse strain background.
High-resolution light microscopy analysis of Abl −/− hearts at E18.5 and P0 revealed that the dramatic increase in organ size was largely caused by an increase in cardiomyocyte cell number rather than cardiac hypertrophy ( Fig. 1D ). It was apparent that, unlike the well organized muscle fibers and smooth oval-shaped nuclei observed in WT mice, the orientation of muscle fibers and the shape of nuclei in Abl-null mice were highly irregular ( Fig.  1D ). More nuclei in the mutant hearts also appeared to undergo mitosis (supported by phospho-histone H3 staining; as described later). Furthermore, the KO hearts exhibited increased interstitial space between cardiomyocytes in the trabecular layer, but Masson trichrome staining showed no evidence of fibrosis ( Fig.  S1 ). This suggests that the mutant hearts were in the early stage of cardiac remodeling (13) . Transmission electron microscopy analysis of E18.5 embryonic hearts from WT and Abl-KO mice revealed that mitochondria were randomly distributed, and large hollow mitochondria characterized by loss of vesicles and cristae were evident in the mutant tissues ( Fig. 1E ). In addition, some sarcomeres in the mutant cardiomyocytes were also fragmented and disorganized with abnormal Z-discs ( Fig. 1E) .
Given the severe morphological defects of Abl −/− hearts, we examined several fetal genes that are typically associated with a cardiac stress response by real-time PCR, including those encoding atrial natriuretic peptide (Nppa), brain natriuretic peptide (Nppb), β-myosin heavy chain (βMHC; Myh7), and smooth muscle α-actin (Acta2). We found all but Acta2 to be significantly up-regulated in E18.5 Abl KO hearts compared with WT controls, a strong indication of cardiac volume overload ( Fig. 1F ). Furthermore, α-myosin heavy chain (αMHC; Myh6) was down-regulated by approximately 30%, consistent with the shift of myosin heavy chain isoform expression from the adult form (αMHC) to the fetal form (βMHC) as seen in failing mouse hearts (14) .
Increased Cardiomyocyte Proliferation in Abl −/− Mice. To investigate the basis for cardiac hyperplasia in Abl 2 KO B6 mice, we analyzed cardiomyocyte apoptosis by TUNEL assay. c-Abl is known to promote apoptosis of several types of cells exposed to genotoxic stress or oxidative stress, and its loss could have resulted in increased cardiomyocyte survival during development (6, 15) . TUNEL staining revealed a very low level of apoptosis (approximately 1 apoptotic cardiac cell/20× field) in both WT and mutant embryonic hearts at E18.5 ( Fig. 2A ). This suggests that cardiac hyperplasia in Abl KO mice is not a result of reduced apoptosis, but is instead caused by elevated cell proliferation.
Cardiac progenitor cells gradually lose their proliferative capacity during later stages of embryogenesis and begin to withdraw from the cell cycle at birth (4, 5) . To determine whether cardiac hyperplasia of Abl mutants was associated with abnormal cell cycle regulation during late gestation, we scored the prevalence of BrdU incorporation (indicator of S phase) and phosphorylation of histone H3 (indicator of M phase) in E18.5 WT and Abl −/− embryonic hearts ( Fig. 2 B-F) . Compared with those from control littermates, ventricular cardiac tissues from Abl KO embryos demonstrated a 1.6-fold increase in BrdUpositive cells (20.1 ± 1.1% vs. 12.7 ± 0.6%; P < 0.002) and a 1.9fold increase in phospho-histone H3 (p-H3)-positive cells (16.0/ 10× field ± 2.1 vs. 8.3/10× field ± 0.9; P < 0.02). Elevated BrdUand p-H3-positive cells were observed throughout both ventricles and the interventricular septum. Although modest, these increases could readily account for tissue hyperplasia observed in the mutant hearts. High-resolution microscopy of tissue sections costained with p-H3 and cardiac myosin heavy chain (MHC) antibodies confirmed that increased mitosis in mutant hearts was primarily confined to cardiomyocytes, rather than cardiac fibroblasts or endothelial cells ( Fig. 2E ). Increased proliferative activity was not observed in any other tissue examined, including brain, lung, liver, and skeletal muscle. Collectively, these data establish that loss of c-Abl results in increased cardiac proliferation during late gestation. The carboxyl-terminal half of c-Abl, encoded by exon 11, con-tains 3 NLSs and one nuclear export signal, which drive its nucleo-cytoplasmic shuttling (6) . DNA-damaging agents promote nuclear translocation of c-Abl and activated nuclear c-Abl has a proapoptotic function (15) . To probe the role of the first NLS (NLS1) in vivo, we introduced an Abl mutant allele, containing a mutated NLS1 (5 amino acid substitutions of Lys to Gln) (16) and a neomycin (neo) resistance cassette flanked by 2 loxP sites, into B6 embryonic stem (ES) cells through homologous recombination (Fig. 3A) . Surprisingly, Western blot analysis showed that the mutant allele expressed barely detectable levels of full-length c-Abl protein and only low levels of a fragment consisting of its N-terminal half ( Fig. 3 B and C) . Subsequent analysis of cDNA from this line revealed the presence of 2 mRNAs with decreased abundance: one apparently of normal structure, and the other formed by joining exon 10 to a portion of the neo cassette, and then to exon 11, encoding a truncated protein ( Fig. 3A and Fig. S2 ). These mutant B6 mice exhibited high perinatal mortality with abnormally enlarged hearts, and were phenotypically indistinguishable from Abl-null mice (Fig.  3E ). We named this allele Abl m3 . When Abl m3 mice were bred to transgenic lines expressing a ubiquitous Cre recombinase (EIIa-Cre) to excise the neo cassette, the resulting Abl nls1 homozygous mice were viable and grossly normal. Western blot analysis of extracts from Abl nls1/nls1 mouse embryonic fibroblasts (MEFs) showed restoration of a full-length c-Abl protein with the same nucleo-cytoplasmic distribution as in WT MEFs (Fig. S3 ). Thus, although the full-length protein retains the mutated NLS1, the mutation does not appear to affect c-Abl steady-state localization. Further study demonstrates that this NLS1 is also dispensable for DNA damage-induced c-Abl nuclear import and apoptosis, suggesting that the trafficking of the mutant protein is still normal (Fig. S3 ).
To determine whether cardiac hyperplasia of mutant mice deficient in c-Abl was due to a cardiomyocyte-autonomous function of c-Abl, we took advantage of the unique Abl m3 mutants and bred them to transgenic B6 mice expressing Cre under the control of the αMHC promoter (17) , which is specifically expressed in differentiated cardiomyocytes from the embryonic stage. Western blot analysis of cardiac extracts from Abl m3/m3 ; αMHC-Cre E18.5 embryos confirmed the efficient restoration of the full-length c-Abl protein to WT control levels (Fig. 3D ). Histological analysis of Abl m3/m3 ; αMHC-Cre newborn hearts showed that both the ventricular walls and interventricular septum were significantly thinner compared with those in Abl m3/ m3 littermates, although still slightly thicker than those in Abl +/m3 controls (Fig. 3E) . As a result, the 2 ventricular lumens were dramatically expanded in Abl m3/m3 ; αMHC-Cre mice. The decreased proliferation in Abl m3/m3 ; αMHC-Cre cardiac tissues was also confirmed by p-H3 staining (Fig. 3E) . These data indicate that c-Abl inhibits proliferation in differentiated cardiomyocytes. Surprisingly, even though the cardiac overproliferation phenotype was largely rescued by c-Abl expression in cardiomyocytes, most Abl m3/m3 ; αMHC-Cre pups still died shortly after birth, suggesting that other defects besides cardiac hyperplasia caused death of these mutants. However, we were unable to identify any obvious abnormalities in other organs of Abl m3/m3 ; αMHC-Cre mice through a histological survey.
Abnormal Gene Expression in Abl −/− Hearts. In further efforts to identify possible molecular defects in Abl 2 KO hearts, we compared the gene expression profiles of E17.5 WT and Abl −/− hearts by microarray analysis. At this stage, mutant hearts exhibited relative minor morphological defects. Numerous gene transcripts showed modest changes (within ±3 fold) in Abl −/− hearts ( Table S2 ). Many of the up-regulated genes encode signaling molecules. Real-time PCR analysis of a subset of the upregulated genes validated approximately half of those examined, suggesting that the subtle changes in the expression of many regulatory genes may contribute to the cardiac abnormalities observed in Abl mutant mice (Fig. 4A) .
We observed a twofold increase in the expression of cardiac ankyrin repeat domain 1 (Ankrd1) and insulin-like growth factor binding protein 3 (Igfbp3) mRNAs in Abl KO hearts using real-time PCR. These 2 genes are associated not only with the cardiac stress response, but also with fetal cardiomyocyte proliferation (18, 19) . Furthermore, Abl mutant hearts showed a slight increase in expression of mRNAs involved in cardiac cell cycle control, including cyclin D1 (Ccnd1) and cyclin D2 (Ccnd2), consistent with elevated cardiomyocyte proliferation in these mice. In line with effects of the mutations on cardiac remodeling, 2 major growth factors involved in tissue remodeling and angiogenesisconnective tissue growth factor (Ctgf) and vascular endothelial growth factor A (Vegfa)-were also up-regulated. Elevated expression of cyclin D1 and CTGF in KO hearts was also confirmed by Western blot analysis of cardiac extracts from E18.5 embryos (Fig. 4B ). CTGF is known to play a key role in the process of cardiac fibrosis through stimulating extracellular matrix production, including various types of collagens (20) . Consistently, immunohistochemical analysis of ventricular sections revealed increased deposition of type I collagen between cardiomyocytes in E19.5 Abl −/− hearts compared with that in control littermates (Fig. 4C ).
Discussion
In summary, we uncovered a physiological function for c-Abl in mammalian heart growth and development. Loss of c-Abl in B6 mice leads to severe cardiac hyperplasia, which contributes to high lethality around the time of birth. The phenotype is dependent on mouse genetic background, as mutant mice deficient of c-Abl protein on several other backgrounds do not show the similar defects and survive much longer. This indicates that the function of c-Abl in cardiac development is subject to modification from other gene(s) in the mouse genome. The situation is similar to that in Drosophila, in which genetic screens have identified a host of Abl modifier genes that either enhance or suppress the phenotype of D-Abl-null animals (21, 22) . For example, mutations in D-Abl have no obvious effects on the morphology of the embryonic CNS, and the mutant animals survive to the pupal and adult stages; however, flies with homozygous mutations in both D-Abl and Disabled fail to develop any axon bundles in the CNS and die at the embryonic and early larval stages (21) . Therefore, it is likely that specific gene allele(s) in the B6 mouse genome can similarly sensitize heart development to mutations in Abl. It will be of interest to identify such modifier gene(s) in future studies.
We show that cardiac hyperplasia observed in Abl KO mice is caused by increased cardiac proliferation during late gestation and can be largely rescued by cardiomyocyte-specific c-Abl expression. c-Abl has long been implicated as a negative regulator of cell growth, as overexpression of c-Abl in fibroblasts induces cell cycle arrest in G1 phase (16, 23, 24) . However, it has been unclear whether endogenous c-Abl plays a role as a true growth inhibitor because previous studies of Abl mutant mice have failed to demonstrate any positive effect of c-Abl deficiency on cell growth (8, 9) . On the contrary, in other settings c-Abl activation has been shown to stimulate cell proliferation (25) (26) (27) .
Here we provide in vivo evidence suggesting that c-Abl acts as a key negative regulator of cardiomyocyte proliferation during later stages of embryogenesis. These findings highlight the multifaceted role of c-Abl in regulating cell proliferation, which is dependent on specific cell types and developmental stages.
The mechanisms by which loss of c-Abl leads to excessive cardiac proliferation are still uncertain. Cyclin D family members have been shown to play a specific role in promoting cardiomyocyte cell cycle progression (28) (29) (30) . Elevated expression of cyclin D1 and cyclin D2 may partially explain the overgrowth phenotype in Abl mutant hearts. But their increases are relatively modest, and it is certainly not the only possible mechanism ( Fig.  4 A and B) . A recent study reports that ephrinB2-EphB4 sig-naling inhibits breast cancer cell proliferation and migration in vivo (31) . These effects are mediated by activation of c-Abl and tyrosine phosphorylation of the adaptor protein Crk, which likely leads to inhibition of Rac1 GTPase activity. EphrinB2-EphB4 signaling is also involved in ventricular trabeculation during early cardiogenesis (32) , but the early lethality of their KO embryos at E11 precludes the analysis of its role in late cardiac development.
In conclusion, our data based on studies in mutant mice show that the c-Abl tyrosine kinase negatively regulates cardiac growth during the late stages of heart morphogenesis. The findings thus raise concerns that exposure to c-Abl inhibitors, as previously suggested (12) , might similarly affect fetal heart development.
Materials and Methods
Mice. Abl m1 and Abl 2 mice used in the study have been previously reported (8, 9) . Homozygous Abl mutant mice and embryos were produced by intercrossing heterozygous parents. The day on which the vaginal plug was observed was designated as E0.5. Abl m3 targeting vector includes exon 11 with the NLS1 mutation, and a neo cassette flanked by loxP sites in the intron between exon 10 and 11. The 5′ arm and 3′ arm of the targeting construct correlate to a 2.4-kb fragment harboring exons 9 to 10, and a 7.2-kb fragment covering the rest of exon 11, respectively. The linearized targeting construct was electroporated into albino B6-derived ES cells. ES cell clones were isolated and analyzed for homologous recombination by Southern analysis. Two properly targeted clones were injected into B6 blastocysts, and 2 resulting male chimeras were crossed to albino B6 females to achieve germline transmission of the targeted allele. Abl m3 mice were mated with 2 Cre lines: EIIa-Cre (JAX 3724) and αMHC-Cre (17), a gift of Ira Goldberg (New York, NY). All animal procedures were approved by the Columbia University Institutional Animal Care and Use Committee.
Histology. Embryos were fixed in neutral buffered 10% formalin (Sigma) at 4°C overnight, embedded in paraffin, and sectioned at 5-μm intervals. H&E and Masson trichrome stains were applied according to standard procedures.
Transmission Electron Microscopy. Embryonic hearts were dissected and immediately fixed with 2.5% glutaraldehyde in 0.1M Sorenson buffer (pH 7.2). Samples were processed by the Columbia University Medical Center Electron Microscope Facility. The sections were examined under a Jeol JEM-1200 EXII electron microscope.
Immunofluorescence. The sections were dewaxed and rehydrated, and incubated with primary antibodies against phospho-histone H3 (ab5176; 1:400; Abcam), cardiac myosin heavy chain (ab15; 1:400; Abcam) and type I collagen (ab34710; 1:600; Abcam). Secondary antibodies conjugated with Alexa Fluor (Invitrogen) or HRP (Vector Laboratories) were then applied. TUNEL assay was performed according to the kit instruction (Roche). Slides were mounted with Vectashield mounting medium with DAPI (Vector Laboratories).
BrdU Incorporation and Staining. Time-pregnant females were intraperitoneally injected with BrdU (50 mg/kg body weight; Sigma). Embryos were dissected 1 h after injection. For staining, sections were incubated with 2 N HCl for 30 min at 37°C and then with BrdU antibody (ab6326; 1:200; Abcam).
Real-Time PCR. Total RNA from ventricular tissue was extracted using TRIzol reagent (Invitrogen) and treated with DNase I (Roche). For real-time PCR, total RNA was reverse-transcribed with random hexamers using the Super-Script III First-Strand cDNA Synthesis System (Invitrogen) to synthesize cDNA. cDNA samples were then used as templates for real-time PCR, which was performed on a 7500 Real-Time PCR System (14) with FastStart SYBR Green Master with Rox (Roche). Primer sequences are available upon request. Gene expression was normalized to Gapdh and calculated as relative fold change.
Western Blot. Ventricular tissue was homogenized in lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40) supplemented with protease inhibitors (Roche). After centrifuging at 15,000 × g for 15 min, supernatant was recovered and protein concentration was determined by the Bio-Rad protein assay. Equal amounts were resolved on a 10% SDS/PAGE gel and analyzed by Western blot using a standard protocol. Primary antibodies against c-Abl [K12; 1:1,000 (Santa Cruz Biotechnologies) and Ab3; 1:1,000 (Calbiochem)], cyclin D1 (sc-753; 1:500; Santa Cruz Biotechnologies), CTGF (ab6992; 1:2,000; Abcam), and α-tubulin (T6199; 1:5,000; Sigma) were applied. Band intensity was quantified by densitometry using ImageJ 
